Factors associated with impaired quality of life three months after being diagnosed with COVID-19
Autor: | Klaus Seppi, Alois Josef Schiefecker, Anna Lindner, Ronny Beer, Piotr Tymoszuk, Mario Kofler, Atbin Djamshidian, Verena Rass, Raimund Helbok, Bogdan-Andrei Ianosi, Stefan Kiechl, Philipp Mahlknecht, Ivan Tancevski, Beatrice Heim, Thomas Sonnweber, Laura Zamarian, Sabina Sahanic, Bettina Pfausler, Christoph Scherfler, Alex Pizzini, Judith Loeffler-Ragg, Victoria Limmert |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Quality of life
Male medicine.medical_specialty Anxiety Hospital Anxiety and Depression Scale Article Cohort Studies COVID-19 Testing Neuro-COVID Internal medicine medicine Humans Prospective Studies Depression (differential diagnoses) business.industry SARS-CoV-2 Depression Hypogeusia Public health Public Health Environmental and Occupational Health COVID-19 Mental health Female medicine.symptom business Cohort study |
Zdroj: | Quality of Life Research |
ISSN: | 1573-2649 0962-9343 |
Popis: | Purpose To assess patient characteristics associated with health-related quality of life (HR-QoL) and its mental and physical subcategories 3 months after diagnosis with COVID-19. Methods In this prospective multicentre cohort study, HR-QoL was assessed in 90 patients using the SF-36 questionnaire (36-item Short Form Health Survey), which consists of 8 health domains that can be divided into a mental and physical health component. Mental health symptoms including anxiety, depression, and post-traumatic stress disorders were evaluated using the Hospital Anxiety and Depression Scale (HADS) and Post-traumatic Stress Disorder Checklist-5 (PCL-5) 3 months after COVID-19. Using descriptive statistics and multivariable regression analysis, we identified factors associated with impaired HR-QoL 3 months after COVID-19 diagnosis. Results Patients were 55 years of age (IQR, 49–63; 39% women) and were classified as severe (23%), moderate (57%), or mild (20%) according to acute disease severity. HR-QoL was impaired in 28/90 patients (31%). Younger age [per year, adjOR (95%CI) 0.94 (0.88–1.00), p = 0.049], longer hospitalization [per day, adjOR (95%CI) 1.07 (1.01–1.13), p = 0.015], impaired sleep [adjOR (95%CI) 5.54 (1.2–25.61), p = 0.028], and anxiety [adjOR (95%CI) 15.67 (3.03–80.99), p = 0.001) were independently associated with impaired HR-QoL. Twenty-nine percent (n = 26) scored below the normal range on the mental health component of the SF-36 and independent associations emerged for anxiety, depression, and self-reported numbness. Impairments in the physical health component of the SF-36 were reported by 12 (13%) patients and linked to hypogeusia and fatigue. Conclusion Every third patient reported a reduction in HR-QoL 3 months after COVID-19 diagnosis and impairments were more prominent in mental than physical well-being. |
Databáze: | OpenAIRE |
Externí odkaz: |